A. Spanevello (Tradate, Italy), R. Louis (Liege, Belgium)
Fixed airflow obstruction in asthma is related to systemic eosinophilic inflammation – Results from the Swedish GA2LEN survey
A. Malinovschi, C. Janson, K. Franklin, B. Forsberg, R. Middelveld, G. Hedlin, S.E. Dahlén, K. Alving (Uppsala, Umeå, Stockholm, Sweden)
|  |
Prediction of new-onset wheeze based on serum inflammation biomarkers – Evaluation using univariate and multivariate techniques
M. Lärstad, M. Josefson, K. Torén, A. C. Olin (Mölndal, Sweden)
| |
Vitamin D insufficiency in adult asthma: Association with asthma severity and control
S. Korn, M. Hübner, M. Jung, M. Blettner, R. Buhl (Mainz, Germany)
| |
Asthma, upper airway disease and systemic inflammation in patients with Churg Strauss syndrome and severe chronic asthma
M. Latorre, F. Novelli, V. Seccia, C. Baldini, P. Iannicelli, F. Dente, M.L. Bartoli, S. Bombardieri, P.L. Paggiaro (Pisa, Italy)
| |
Airway and systemic inflammation during Churg-Strauss syndrome natural course
M. Latorre, C. Baldini, F. Novelli, F. Dente, S. Bombardieri, P.L. Paggiaro (Pisa, Italy)
| |
Calprotectin – A marker of mortality in COPD? Results from a prospective cohort study
D.B. Holmgaard, L.H. Mygind, I.L. Titlestad, H. Madsen, S.S. Pedersen, O.H. Mortensen, C. Pedersen (Odense, Aalborg, Copenhagen N, Denmark)
|  |
Collagen degradation profile in serum of patients with COPD or IPF
F. Genovese, J. Sand, M. Nielsen, F. J. Martinez, C.M. Hogaboam, M- Han, M. Karsdal, D. Leeming (Herlev, Denmark)
|  |
Downregulation of Th 17 response after low dose clarithromycin in non-CF bronchiectasis patients
E. Fouka, I. Kotsianidis, G. Kolios, P. Miltiades, K.I. Arvanitidis, E. Filidou, E. Paraskakis, P. Zarogoulidis, E. Kalaitzidou, D. Bouros (Thessaloniki, Alexandroupolis, Greece)
| |